Skip to main content

Advertisement

SpringerLink
Log in

Observation of therapeutic effects of point application at Shenque (CV 8) plus moxa-salt hot compress for prevention of gastrointestinal adverse reactions after chemotherapy for non-Hodgkin lymphoma

穴位贴敷神阙加艾盐热敷预防非霍奇金淋巴瘤化疗消化道不良反应效果观察

  • Clinical Study
  • Published:
Journal of Acupuncture and Tuina Science Aims and scope Submit manuscript

Abstract

Objective

To observe the clinical efficacy of point application with Da Huang (Rhizoma Rhei Cruda) powder at Shenque (CV 8) plus moxa-salt hot compress on the umbilicus for preventing gastrointestinal adverse reactions after chemotherapy for non-Hodgkin lymphoma (NHL).

Methods

A total of 60 cases with NHL under chemotherapy were divided into two groups by hospitalization order, with 30 cases in each group. The control group was treated with routine nursing and the observation group was additionally given point application with Da Huang (Rhizoma Rhei Cruda) powder plus moxa-salt hot compress on the umbilicus, to compare the effect in preventing gastrointestinal adverse reactions after chemotherapy between the two groups.

Results

The occurrence rates of constipation, nausea, vomiting and poor appetite on the second day and fifth day after chemotherapy were obviously lower in the observation group than those in the control group, with statistically significant differences between the two groups (all P<0.05).

Conclusion

The point application with Da Huang (Rhizoma Rhei Cruda) powder at Shenque (CV 8) plus maxa-salt hot compress on the umbilicus can produce more significant efficacy in preventing the gastrointestinal adverse reactions after chemotherapy for NHL than routine nursing. Moreover, it is simple and easy to be used and popularized.

摘要

目的

观察生大黄粉贴敷神阙加艾盐包热敷脐部预防非霍奇金淋巴瘤(NHL)化疗后消化道不良反应的临床疗效。

方法

将60例NHL化疗患者按入院先后顺序分为两组, 每组30例。对照组采用常规护理, 观察组在常规护理基础上采用生大黄粉贴敷神阙加艾盐热敷脐部治疗。比较两组预防化疗后消化道不良反应的效果。

结果

观察组化疗后第2天、第5天的便秘、恶心呕吐和食欲不振发生率均明显低于对照组, 组间差异有统计学意义(均P<0.05)。

结论

生大黄粉贴敷神阙加艾盐热敷脐部预防NHL化疗后消化道不良反应的效果明显优于常规护理, 且方法简易, 便于实施和推广。

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Xiong WJ, Li H, Liu HM, Yi SH, Li ZJ, Lü R, Liu W, Zou DH, Qiu LG. Divergence analysis of hepatitis virus infection between aggressive and indolent B cell non-Hodgkin’s lymphoma. Zhonguo Shiyan Xueyexue Zazhi, 2016, 24(6): 1754–1758.

    Google Scholar 

  2. Zhang Y, Xu N, Dong BJ, Song G, Li QH, An G, Ai XF. Diagnostic significance of BIOMED-2 standardized gene rearrangement system in patients with non-Hodgkin’s lymphoma. Zhonguo Shiyan Xueyexue Zazhi, 2017, 25(1): 115–119.

    Google Scholar 

  3. Wang XQ, Fang BM, Jiang JH, Qu ZG, Liu YH, Ma GL, Yu K. Clinical efficacy and safety of thalidomide combined with CHOP regiment in the treatment of aggressive non-Hodgkin’s lymphoma. Zhongguo Linchuang Yaolixue Zazhi, 2015, 31(16): 1588–1590.

    Google Scholar 

  4. Dong F, Sui AX, Jing HM. Expression of lactate dehydrogenase-5 in non-Hodgkin lymphoma and its clinical significance. Zhongnan Daxue Xuebao (Yixue Ban), 2016, 41(12): 1312–1316.

    Google Scholar 

  5. Yang XL, Wu YM, Cao YB, Li XH, Xu LX, Liu ZY, Liu B, Yan B, Li SW, Da WM, Wu XX. Clinical efficacy of autologous hematopoietic stem cell transplantation using tumor-ablative conditioning regimen for patients with refractory-relapsed non-Hodgkin’s lymphoma. Zhongguo Shiyan Xueyexue Zazhi, 2016, 24(6): 1743–1747.

    PubMed  Google Scholar 

  6. Zhang YP, Zhou XH, Zhang L, Ma GL. Rituximab combined with CHOP chemotherapy regimen in the treatment of relapsing non-Hodgkin’s lymphoma. Zhongguo Linchuang Yaolixue Zazhi, 2015, 31(12): 1109–1111.

    Google Scholar 

  7. Tang Y, Wang W, Gao L, Sun Y, Gao YY, Zhang CX, Gong M, Huang FZ, Li ZL, Ma YG. Application of cytogenetic test for diagnosis of bone marrow involvement in patients with non-Hodgkin’s lymphoma. Zhongguo Shiyan Xueyexue Zazhi, 2016, 24(3): 727–732.

    PubMed  Google Scholar 

  8. Jiang L, Zhu ZM, Zhou F, Yuan XL. miR-125b targets Sema4C regulating invasion and migration of non- Hodgkin’s lymphoma by STAT3 signaling pathway involved. Zhongguo Mianyixue Zazhi, 2017, 33(7): 1018–1022, 1028.

    Google Scholar 

  9. Zhang D, Xia ZW. Rome III diagnostic criteria: functional constipation. Zhongguo Yikan, 2008, 43(12): 63–64.

    Google Scholar 

  10. Osoba D, Zee B, Pater J, Warr D, Latreille J, Kaizer L. Determinants of postchemotherapy nausca and vomiting in patients with cancer. Quality of Life and Symptom Control Committees of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol, 1997, 15(1): 116–123.

    Article  PubMed  CAS  Google Scholar 

  11. Zhang TZ, Xu GW. Oncology. 2nd Edition. Tianjin: Tianjin Science and Technology Press, 1996: 2638.

    Google Scholar 

  12. Ping LY, Song YQ, Zheng W, Wang XP, Xie Y, Lin NJ, Tu MF, Ying ZT, Liu WP. Efficacy and survival analysis of DICE regimen for 97 patients with relapsed or refractory non-Hodgkin’s lymphoma. Zhonghua Xueyexue Zazhi, 2016, 37(9): 790–794.

    PubMed  CAS  Google Scholar 

  13. Yao ZH, Wu CF, Liu WG, Ren ZQ, Liu Y, Zhan XX, Guo LM. Pharmaceutical care of 1 case of pulmonary infection after radiochemotherapy for non-Hodgkin’s lymphoma. Yiyao Daobao, 2016, 35(2): 200–202.

    Google Scholar 

  14. Guo J, Zhu YP, Gao J, Li Q, Jian CS, Zhou CY, Guo X. Clinical and prognostic analysis of 43 children with mature B-cell non-Hodgkin’s lymphoma/acute lymphoblastic leukemia. Zhongguo Shiyan Xueyexue Zazhi, 2016, 24(1): 72–79.

    PubMed  Google Scholar 

  15. Lin JF, Zeng ZY, Yang AP, Zheng L, Chen JM. Effect of complicated hemophagocytic syndrome on clinical prognosis of patients with non-Hodgkin’s lymphoma and analysis of its affecting factors. Zhongguo Shiyan Xueyexue Zazhi, 2017, 25(4): 1042–1046.

    PubMed  Google Scholar 

  16. Chen X, Wang H, Zhang Y, Shen L, Liu QR, Liu HT, Chai T, Xu Q, Fu Y. Therapeutic effects of individualized grouping treatment for senile non-Hodgkin’s lymphoma. Zhongguo Laonianxue Zazhi, 2015, 35(11): 3018–3019.

    Google Scholar 

  17. Hu CJ, Wang YJ. Clinical observations on moxibustion plus acupoint application for the prevention and treatment of gastrointestinal reactions during chemotherapy for breast cancer. Shanghai Zhenjiu Zazhi, 2016, 35(10): 1219–1221.

    Google Scholar 

  18. Pang GS, Chen ZL. Therapeutic observation of acupuncture plus turtle-shell-partitioned moxibustion for diarrhea-predominant irritable bowel syndrome. J Acupunct Tuina Sci, 2016, 14(1): 22–25.

    Article  Google Scholar 

  19. Hong JN, Cai YH. Therapeutic observation of hot application with moxa-salt pack for diarrhea due to chemotherapy with irinotecan. Shanghai Zhenjiu Zazhi, 2016, 35(2): 144–145.

    Google Scholar 

  20. Xu LY, Liu ZH, Li W, Gao YT. Expression and significance of CCL22, IL-10 and FOXP3 in tissues of B-cell non-Hodgkin’s lymphoma. Shandong Yiyao, 2015, 35(14): 59–61.

    Google Scholar 

  21. Li Y, Li MJ, Lian M. Efficacy of rituximab combined with CHOP chemotherapy for 35 patients with aggressive B cell non-Hodgkin’s lymphoma. Zhongguo Shenghua Yaowu Zazhi, 2015, 35(12): 168–170.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dongyang People’s Hospital, Zhejiang Province, Dongyang, 322100, China

    Yan-fei Guo  (郭燕飞) & Qun-ling Hu  (胡群玲)

  2. Zhejiang Tumor Hospital, Hangzhou, 310022, China

    Yang-yang Cai  (蔡阳阳) & Xiao-wei Fu  (傅晓炜)

Authors
  1. Yan-fei Guo  (郭燕飞)
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Qun-ling Hu  (胡群玲)
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yang-yang Cai  (蔡阳阳)
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Xiao-wei Fu  (傅晓炜)
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yan-fei Guo  (郭燕飞).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Guo, Yf., Hu, Ql., Cai, Yy. et al. Observation of therapeutic effects of point application at Shenque (CV 8) plus moxa-salt hot compress for prevention of gastrointestinal adverse reactions after chemotherapy for non-Hodgkin lymphoma. J. Acupunct. Tuina. Sci. 16, 248–252 (2018). https://doi.org/10.1007/s11726-018-1058-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11726-018-1058-7

Keywords

关键词

中图分类号

文献标志码

Search

Navigation